Iovance Biotherapeutics, Inc. · NASDAQ:IOVA
Iovance Biotherapeutics, Inc. shareholders
As of Jun 30, 2026, 282 institutions reported holding Iovance Biotherapeutics, Inc., 63.3% of its shares. Largest: BlackRock, Vanguard and Mhr Fund Management LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Iovance Biotherapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 37M | 8.2% | +5.88M | Aug 7, 2026 |
| Vanguard | 35.7M | 7.9% | +4.78M | Aug 13, 2026 |
| Mhr Fund Management LLC | 29M | 6.4% | no change | Aug 14, 2026 |
| State Street | 24.5M | 5.4% | +7.03M | Aug 7, 2026 |
| Two Sigma | 19M | 4.2% | +5.32M | Aug 14, 2026 |
| Geode Capital | 10.3M | 2.3% | +1.75M | Aug 12, 2026 |
| Millennium | 8.53M | 1.9% | −888K | Aug 14, 2026 |
| Dimensional | 6.46M | 1.4% | +3.81M | Aug 11, 2026 |
| Palo Alto Investors LP | 5.3M | 1.2% | −1.05M | Aug 19, 2026 |
| Goldman Sachs | 5.1M | 1.1% | −3.66M | Aug 14, 2026 |